ResMed (RMD) DIvidends Date & History

Key Takeaways

• ResMed Inc. (RMD) offers a modest dividend yield of approximately 1.23% with quarterly payments of $0.60 per share.
• The company has raised its dividend for 13 consecutive years, reflecting consistent growth.
• Payout ratio stands at about 22%, indicating strong earnings coverage and sustainability.
• Free cash flow supports dividend payments comfortably, with low debt levels enhancing stability.
• The stock appeals primarily to dividend growth investors seeking long-term compounding in the healthcare sector.
• Yield is below the healthcare industry average, positioning it as a conservative income option rather than a high-yield play.

Dividend Overview

ResMed Inc. (RMD) maintains a quarterly dividend policy, distributing $0.60 per share four times annually for an annualized total of $2.40. This results in a current yield near 1.23%, based on prevailing share prices. The company qualifies as a dividend growth stock rather than a high-yield name, emphasizing gradual increases supported by robust earnings and cash generation in the medical devices industry. Payments occur on a regular schedule, with recent ex-dividend and payment dates aligning to standard quarterly cycles. Investors receive reliable but modest income, suited for those prioritizing sustainability over immediate high returns.

Dividend History and Growth

ResMed Inc. (RMD) has demonstrated a strong track record of dividend growth, increasing payouts for 13 consecutive years. Annualized growth rates average 12.56% over the past 12 months, 10.22% over three years, and around 7-8% over longer periods such as five and ten years. The dividend per share has risen steadily from lower levels in prior years to the current $0.60 quarterly rate, with no cuts observed. This consistency reflects a deliberate long-term strategy focused on returning capital to shareholders while reinvesting in business expansion. The streak underscores management’s confidence in sustained profitability within the sleep and respiratory care markets.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable, backed by a low payout ratio of approximately 22-23% of earnings. This leaves ample room for future increases and buffers against earnings volatility. Free cash flow coverage is similarly strong, with cash payouts to shareholders around 20%, supported by healthy operating cash generation and a solid balance sheet with low debt. ResMed Inc. (RMD) maintains financial stability through consistent revenue growth and operational efficiency, reducing risk of dividend interruption. Overall metrics point to a conservative approach that prioritizes long-term viability over aggressive distributions.

Dividend Compared to Industry Peers

Within the healthcare sector, particularly medical equipment and devices, ResMed Inc. (RMD)’s yield of about 1.23% sits below the industry average of roughly 1.56-1.7%. Peers often offer higher yields but may carry elevated payout ratios near 37%. ResMed’s profile stands out for its lower risk profile, driven by superior earnings coverage and a proven growth streak. This positions the stock as offering below-average income but stronger growth potential and safety compared to higher-yielding healthcare names.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener today.

Is This Stock Attractive for Dividend Investors?

ResMed Inc. (RMD) suits dividend growth investors seeking steady compounding in a defensive healthcare sector rather than those prioritizing high current income. Its low payout ratio, consistent increases over more than a decade, and strong free cash flow coverage make it appealing for long-term holders focused on capital preservation and gradual yield expansion. Conservative investors may value the modest yield and financial stability, while income-focused portfolios might find it complementary to higher-yielding holdings. The stock’s profile supports suitability for patient, growth-oriented dividend strategies without excessive risk from high leverage or payout pressures. Performance depends on broader market conditions and company execution in its core markets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations